abrdn Life Sciences Investors (HQL) vs RENN Fund (RCG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 5.1x for RENN Fund). abrdn Life Sciences Investors offers the higher dividend yield (10.96% vs 0.73%).
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | HQL | RCG |
|---|---|---|
| Share price | $17.42 | $2.87 |
| 1-day change | -0.80% | -0.17% |
| YTD return | +4.65% | — |
| 1-year return | +11.21% | — |
| 5-year return | -15.00% | — |
| P/E ratio (TTM) | 2.62 | 5.13 |
| EPS (TTM) | $6.64 | $0.56 |
| Dividend yield | 10.96% | 0.73% |
| Annual dividend | $1.91 | $0.021 |
| 52-week high | $22.67 | $3.31 |
| 52-week low | $15.66 | $2.45 |
| Distance from 52-week high | -23.16% | -13.29% |
| Average volume | 147.31K | 6.02K |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RENN Fund trades at a higher earnings multiple (5.1x vs 2.6x trailing P/E).
- abrdn Life Sciences Investors offers a meaningfully higher dividend yield (10.96% vs 0.73%).
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
HQL vs RCG FAQ
Which has the lower P/E ratio, HQL or RCG?
HQL has the lower trailing P/E at 2.6, versus 5.1 for RCG. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, abrdn Life Sciences Investors or RENN Fund?
abrdn Life Sciences Investors has the higher yield at 10.96%, compared with 0.73% for RENN Fund.
Are abrdn Life Sciences Investors and RENN Fund in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.